circRNA basic information
circBase ID: hsa_circ_0004087
Name: hsa_circ_CDYL2
Synonym: circ_0004087
Host Gene: CDYL2
Genomic location(hg19): chr16:80718434-80719026:-
Genomic location(hg38): chr16:80684537-80685129:-
Subcellular localization: nucleus
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0008315
MONDO name: prostate cancer
Disease details: prostate cancer / PCa
Disease DO ID:
10283
Disease MeSH ID:
D011471
Disease NCIt ID:
C7378
Disease ICD11 ID:
-
Disease OMIM ID:
-
Species: Human
Species details: Homo sapiens
Tissue specimen:

PCa tissues; adjacent noncancerous tissues

Cell lines:

RWPE-1; 22Rv1; PC-3; DU145; LNCaP; C4-2; PC-3-DR

In vivo animal model:

cell line-derived xenograft

circRNA-disease information
Expression pattern:
UP
Associated gene: SND1, MYB, BUB1, CPC
Associated microRNA: -
Biological function: Promotes docetaxel (DTX) resistance in prostate cancer cells; reduces DTX-induced apoptosis; supports error-free mitosis via mitosis error correction.
Molecular mechanism: circ_0004087 forms a circRNA-protein complex with SND1, enhancing SND1-mediated MYB transactivation, increasing BUB1 expression; BUB1 promotes CPC recruitment to centromeres to strengthen mitosis error correction, leading to DTX chemoresistance.
Biological pathway or process:

chemoresistance (promotes); apoptosis (inhibits); cell cycle (promotes); other pathway/process (promotes)

Detected method:
Q
S
M
Validation methods:

Bioinformatics Analysis; RT-qPCR; Back-Splice Junction PCR / divergent primers PCR; Sanger Sequencing; RNase R Treatment; Agarose Gel Electrophoresis; FISH / smFISH; Nuclear-Cytoplasmic Fractionation; RNA Pull-Down; RIP (RNA Immunoprecipitation); Co-IP; Luciferase Reporter Assay; Transfection; Annexin V/PI Flow Cytometry; In Vivo Animal Model; TUNEL; RNA-seq; Western Blot; Mass Spectrometry; Microarray

Clinical significance:

circ_0004087 may serve as a valuable prognostic biomarker and a potential therapeutic target in DTX-resistant PCa patients.

Description:

circ_0004087 is upregulated in prostate cancer and promotes docetaxel resistance. It localizes mainly in the nucleus and binds SND1, enhancing SND1-mediated MYB transactivation to increase BUB1 expression, which strengthens CPC-dependent mitosis error correction and reduces DTX-induced apoptosis.

Confidence score:

0.8293

Other information
Title:

Circ_0004087 interaction with SND1 promotes docetaxel resistance in prostate cancer by boosting the mitosis error correction mechanism.

Journal: Journal of experimental & clinical cancer research : CR
Published: 2022
PubMed ID: 35659274
Study type:

combined biological and clinical study

Data availability: available from the corresponding author on reasonable request
Code availability: -